QP
LCTX icon

Quilter Plc’s Lineage Cell Therapeutics LCTX Stock Holding History

Quilter Plc’s Portfolio LCTX Stock Details LCTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-24,873
Closed -$70K – 363
2021
Q2 		$70K Buy
24,873
+10,699
+75% +$27.7K ﹤0.01% 340
2021
Q1 		$33K Hold
14,174
– – ﹤0.01% 351
2020
Q4 		$25K Hold
14,174
– – ﹤0.01% 297
2020
Q3 		$13K Hold
14,174
– – ﹤0.01% 283
2020
Q2 		$12K Hold
14,174
– – ﹤0.01% 277
2020
Q1 		$12K Hold
14,174
– – ﹤0.01% 258
2019
Q4 		$13K Buy
+14,174
New +$11.8K ﹤0.01% 221

Other funds holding LCTX

BC
Broadwood Capital New York $1.91B AUM 44.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.96B AUM 58.65% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Quilter Plc's LCTX Position: Q3 2021 in Review

Quilter Plc sold out of Lineage Cell Therapeutics (LCTX) in Q3 2021, closing a stake of 24,873 shares — an estimated $70K sold.

Quilter Plc first reported a position in LCTX in Q4 2019 and held it in 7 quarters. The position peaked at $70K in Q2 2021. 115 funds tracked by Wall St. Rank hold LCTX as of Q3 2021.

  • Quilter Plc reported no remaining Lineage Cell Therapeutics position as of Q3 2021 after selling out during the quarter.
  • Quilter Plc sold 24,873 Lineage Cell Therapeutics shares in Q3 2021, an estimated $70K.
  • Quilter Plc first reported a position in Lineage Cell Therapeutics in Q4 2019 and held it in 7 quarters.
  • Quilter Plc's Lineage Cell Therapeutics position peaked at $70K in Q2 2021.
  • 115 funds tracked by Wall St. Rank held Lineage Cell Therapeutics as of Q3 2021.

Based on Quilter Plc's 13F filing for Q3 2021, filed 4 Nov 2021.